Schedule 13D ownership disclosure
Niagen Bioscience Inc
Security class unavailable · CUSIP: 171077407
Event date: 2022-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.7700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-256196
- Form type
- SC 13D
- Filer
- Niagen Bioscience, Inc.
- CIK
- CIK 1386570
- Filed
- Oct 03, 2022
- Reporting period
- Sep 30, 2022
- Description
- Schedule 13D beneficial ownership